we all accept that a back pain can be musculotendinous in origin can we not also accept that a front pain could arise in the abdominal wall?
A F HIGGINS
Consultant Surgeon Hinchingbrooke Hospital Huntingdon
Carpal tunnel syndrome in lactation This interesting article by Wand (June 1989 JRSM, p 349) sadly omitted to mention the results of treatment. It is interesting that only 26% of the patients were given a splint and 11% a steroid injection, whereas over a third (37%) were given 're-assurance'. Is one to assume that those given 're-assurance' did not have symptoms warranting any treatment? After all, the article did state that 'all patients had sought the attention of their general practitioners for this condition'. One would certainly not like to think that patients whose symptoms were severe enough to take them to their doctor were denied an effective treatment which could easily be supplied by their GP.
M C T MORRISON FRCS Consultant Orthopaedic Surgeon

*The author replies below:
I would like to thank Mr Morrison for his comments concerning my paper. The results of treatment for carpal tunnel syndrome are outlined in Table 2 . As MrMorrison points out, only two-thirds of the patients were offered treatment. While this was generally effective, it did not entirely cure symptoms except when a carpal tunnel decompression had been performed. Indeed, the patients treated with diuretics had a relatively mild improvement in their symptoms, and in most patients their symptoms had returned within three weeks of treatment. Perhaps the reluctance of general practitioners to offer 'effective' treatment to these women rests on their understanding that the condition is self-limiting, and that treatment (short of surgery) is relatively ineffective. J WAND
Queen Mary's University Hospital London
Italian psychiatric care May I please add a little to Caparrotta's interesting paper on this subject (August 1989 JRSM, p 452)? During a study tour of the Royal College of Psychiatrists to Italy in May 1988 1 we were told that mentally abnormal people who committed trivial offences and who would before the passing of Law 180 in 1978 have been admitted to ordinary mental hospitals were being taken instead to Italy's five forensic hospitals, under the organization of the Minister of Justice, where the patient population had increased by up to a thousand per hospital.
We were told too that of another avenue into which psychiatric patients might travel-suicide -there was press silence and that only 'legal doctors' knew the rate but at least one Italian psychiatrist thought it was increasing.
On the other hand we heard that whereas before 1978 psychiatry had depended on public charity, psychiatric patients and staff having been secondclass citizens, the Law had integrated psychiatry into the National Health Serivce. Inflammatory bowel disease and chronic diffuse hair loss I was interested to see the case report from Schattner and Shanon on Crohn's ileocolitis presenting as chronic diffuse hair loss (May 1989 JRSM, p 303). I have recently seen a 42-year-old female with ulcerative colitis, whose first symptom was a long period of diffuse hair loss.
For six months prior to her first attack of ulcerative colitis at the age of 40, she had noticed generalized increased shedding of hair. At this time she had no bowel symptoms, was haematologically and biochemically normal and was not taking any drug associated with hair loss. After the development of bowel symptoms, ulcerative colitis was confirmed by biopsy and barium enema. She was treated with Colifoam. and mesalazine and, in the subsequent period of remission the hair loss ceased.
After remaining well for 18 months, in which treatment with mesalazine was continued, she suffered a further attack of ulcerative colitis. Once again, she noticed a period of diffuse hair loss prior to the relapse and when she was quite well in all other ways.
There are no reports in the literature of hair loss associated with ulcerative colitis. Alopecia has been reported in association with treatment with sulphasalazine-, but not with mesalazine.
Each of these two attacks of ulcerative colitis was preceded by a period of chronic diffuse hair loss. Hair loss may be a more common manifestation of inflammatory bowel disease than has been appreciated in the past. J MARLEY General Practitioner Newbury
